Pacific Biosciences Of California (PACB) Amortizatization of Intangibles (2021 - 2026)
Pacific Biosciences Of California (PACB) posted Amortizatization of Intangibles of $664000.0 for Q2 2026, down 21.79% on a QoQ basis from $849000.0 in Q1 2026, and down 26.55% year-over-year from $904000.0 in Q2 2025.
Analysis
Pacific Biosciences Of California (PACB) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Pacific Biosciences Of California has reported Amortizatization of Intangibles for 6 years, with the latest figure at $664000.0 in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 26.55% year-over-year to $664000.0 in Q2 2026; TTM through Jun 2026 was $3.3 million, a 60.7% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 67.31% from the prior year.
- Amortizatization of Intangibles was $664000.0 for Q2 2026 at Pacific Biosciences Of California, down from $849000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $5.1 million in Q3 2024, with the low at $664000.0 in Q2 2026.
- Average Amortizatization of Intangibles over 5 years is $1.7 million, with a median of $1.7 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles surged 213.91% in 2024, then sank 81.78% in 2025.
- Over 5 years, Amortizatization of Intangibles stood at $1.8 million in 2022, then grew by 5.47% to $1.9 million in 2023, then tumbled by 32.99% to $1.3 million in 2024, then dropped by 28.65% to $894000.0 in 2025, then retreated by 25.73% to $664000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $664000.0 (Q2 2026), $849000.0 (Q1 2026), and $894000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | - |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | - |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | - |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 4.71 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 2.02 Mn |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | 664,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 664,000.00 |
| Mar 31, 2026 | 849,000.00 |
| Dec 31, 2025 | 894,000.00 |
| Sep 30, 2025 | 921,000.00 |
| Jun 30, 2025 | 904,000.00 |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 5.05 Mn |
| Jun 30, 2024 | 3.94 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Jun 30, 2021 | 801,000.00 |